Brainsway USA Announces New Headquarters

Brainsway® USA Inc., a company focused on the treatment of brain disorders, announced today that it has moved its US headquarters to Hackensack. Brainsway’s move to the greater New York metropolitan area comes on the heels of its highest revenue generating quarter in its history. The company makes the relocation from its original headquarters in Philadelphia.

“Placing our U.S. Headquarters in the largest metro area in the U.S. signifies our commitment to continued investment in the U.S. market. Furthermore, this move gives us a stronger national presence, allowing us increased access to better service our customers across the country,” said Joseph Perekupka, VP of North American Sales Operations. “Deep TMS is now used in 40 states across the country, having gained significant traction since our U.S. launch at the end of 2014. We’re very excited to bring our headquarters to this dynamic market.”

Greater New York was selected due to the region’s foothold in healthcare coupled with its advanced business ecosystem. Brainsway will continue to expand, as it grows its staff in order to strengthen the companies’ services – everything from client services to tech support.

Developed in conjunction with the NIH, Brainsway Systems are now deployed in major academic centers and U.S. military institutions across the country. Deep TMS – a helmet that sends magnetic fields into the brain to non-invasively provide relief – is being used by some of the top physicians in the U.S. Resistance to treatment has been a growing concern, affecting up to half of the 15 million Americans suffering from depression. As such, the medical community has expressed a significant need for Deep TMS.

Related Articles: